Internal Medicine, Endocrinology, Diabetes, & Metabolism · Arvada, CO
NPI
1720068760
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
15389 W 91st Dr Ste 200
Arvada, CO, 80007
Phone (303) 403-7933
Groups this clinician bills Medicare through
Medicare paid, 2024
$49K
651 services
Medicare patients, 2024
181
Average age 73
Drug cost, 2024
$5.9M
695 prescriptions
Company payments, 2025
$12K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Irinel Stanciu was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 274 times for 169 patients. In total Irinel Stanciu billed 651 services in 10 codes, and Medicare paid $49K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-30.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 274 | 169 | $12.91 | $3,538 |
| 99215 Office E&M - Established | Office | 193 | 142 | $141.97 | $27K |
| 99214 Office E&M - Established | Office | 90 | 73 | $100.91 | $9,082 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 39 | 29 | $25.64 | $1,000 |
| 99205 Office E&M - New | Office | 31 | 31 | $171.10 | $5,304 |
| 99204 Office E&M - New | Office | 13 | 13 | $125.73 | $1,634 |
By year: 2022 $19K for 285 services; 2024 $49K for 651 services.
Medicare prescription drug claims, 2024
In 2024, the drug Irinel Stanciu prescribed most often to Medicare patients was Tymlos (Abaloparatide), with 136 prescriptions and refills. In total Irinel Stanciu wrote 695 Medicare prescriptions that cost $5.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tymlos Abaloparatide | 136 | 140 | 28 | $402K |
| Alendronate Sodium Generic | 92 | 206 | 35 | $503 |
| Levothyroxine Sodium Generic | 88 | 222 | 36 | $920 |
| Indapamide Generic | 65 | 129 | 18 | $742 |
| Potassium Citrate Er Potassium Citrate | 65 | 142 | 17 | $5,640 |
| Amiloride Hcl Generic | 43 | 97 | 15 | $579 |
| Strensiq Asfotase Alfa | 39 | 39 | Under 11 | $5.3M |
| Metformin Hcl Er Metformin Hcl | 24 | 56 | Under 11 | $251 |
| Forteo Teriparatide | 17 | 26 | Under 11 | $119K |
| Synthroid Levothyroxine Sodium | 13 | 30 | Under 11 | $868 |
| Mounjaro Tirzepatide | 13 | 13 | Under 11 | $13K |
Brand drugs: 351 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Irinel Stanciu $12K ($12K in general payments such as food, travel and fees) from 12 companies. The largest payer was Alexion Pharmaceuticals, Inc. with $5,990.
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. AZN | 7 | $5,990 |
| Amgen Inc. AMGN | 7 | $5,720 |
| Radius Health, Inc. | 2 | $148 |
| Kyowa Kirin, Inc. 4151.T | 1 | $122 |
| Novo Nordisk Inc NVO | 1 | $121 |
| Dexcom, Inc. DXCM | 2 | $43.2 |
| Abbott Laboratories ABT | 1 | $26.82 |
| Tandem Diabetes Care, Inc. TNDM | 1 | $26.24 |
| Ascendis Pharma Endocrinology Inc ASND | 1 | $19.45 |
| Beta Bionics, Inc. BBNX | 1 | $18.67 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.